Dr Estela L Chan, MD in Red Cloud, NE - Medicare General Practice

Dr Estela L Chan, MD is a medicare enrolled "General Practice" physician in Red Cloud, Nebraska. Her current practice location is 145 W 3rd Ave, Red Cloud, Nebraska. You can reach out to her office (for appointments etc.) via phone at (402) 746-3646.

Dr Estela L Chan is licensed to practice in Nebraska (license number 14917) and she also participates in the medicare program. She does not accept medicare assignments directly but she may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. Her NPI Number is 1942315023.

Contact Information

	Dr Estela L Chan, MD
	145 W 3rd Ave, Red Cloud, NE 68970-2542
	(402) 746-3646
	(402) 746-3519

Physician's Profile

Full Name	Dr Estela L Chan
Gender	Female
Speciality	General Practice
Location	145 W 3rd Ave, Red Cloud, Nebraska
Accepts Medicare Assignments	Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.

NPI Data:

NPI Number: 1942315023
Provider Enumeration Date: 08/20/2006
Last Update Date: 07/11/2008

Medicare PECOS Information:

PECOS PAC ID: 2466518790
Enrollment ID: I20090311000321

Medical Identifiers

Medical identifiers for Dr Estela L Chan such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1942315023	NPI	-	NPPES
36303170800	Medicaid	NE

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208D00000X	General Practice	14917 (Nebraska)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Estela L Chan is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Estela L Chan, MD 145 W 3rd Ave, Red Cloud, NE 68970-2542 Ph: (402) 746-3646	Dr Estela L Chan, MD 145 W 3rd Ave, Red Cloud, NE 68970-2542 Ph: (402) 746-3646

News Archive

Abbott's CREON receives FDA approval for infant-specific dose

Abbott announced today that the U.S. Food and Drug Administration (FDA) has approved an infant-specific dose of CREON® (pancrelipase) Delayed-Release Capsules to treat exocrine pancreatic insufficiency (EPI) due to cystic fibrosis (CF). The CREON 3,000 units of lipase capsule provides the lowest dosage strength in the class approved by the FDA. This new option will enable more precise dosing titration in accordance with the Cystic Fibrosis Foundation guidelines for infant dosing.

Invida to continue commercialization of Actelion's Tracleer for PAH in crucial Asian markets

Invida Group, the leading provider of healthcare brands and services to the Asia Pacific region, today announced that its contract with Swiss biotechnology company, Actelion, has been extended through 2015 to continue commercialization of Tracleer® for the treatment of pulmonary arterial hypertension (PAH) in crucial markets throughout Asia. Actelion signed with Invida initially in 2005, and has extended the contract to market the company's lead product, Tracleer, in Thailand, Malaysia, Philippines, Vietnam, and Hong Kong

Experts warn about electronic cigarettes

The U.S. Food and Drug Administration today announced that a laboratory analysis of electronic cigarette samples has found that they contain carcinogens and toxic chemicals such as diethylene glycol, an ingredient used in antifreeze.

Study confirms that higher level of maternal folate increases the child's birthweight

Imagine that you are going to conduct research on how different factors affect a child in the womb. Bad habits such as smoking, drinking alcohol or poor eating habits are factors that may affect the child.

Luminex to acquire molecular diagnostics company, GenturaDx

Luminex Corporation today announced a definitive agreement to acquire privately-held, GenturaDx, a molecular diagnostics company focused on making nucleic acid testing both affordable and practical for any laboratory. GenturaDx is in late stage development of a fully integrated, highly automated, real-time PCR system that employs a single-use cassette for true sample-to-answer workflow.

Dr Estela L Chan, MD - Medicare General Practice in Red Cloud, NE